Stock analysis searches answered, part 4 of 43

Silver pegasus acquisition corp. bullish and bearish analyst opinions

This section ties “Silver pegasus acquisition corp. bullish and bearish analyst opinions” to Silver Pegasus Acquisition Corp. (ticker SPEG, SPEGR, SPEGU), SEC Central Index Key 2028735, an EDGAR registrant classified as “Blank Checks” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-24 by Silver Pegasus Acquisition Corp. (CIK 2028735) — source document:

We are a blank check company incorporated on June 5, 2024 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Report as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination target in any business or industry or at any stage of its corporate evolution. Our primary focus, however, will be in completing a business combination with an established business of scale poised for continued growth, led by a highly regarded management team.

Financial trend for Silver Pegasus Acquisition Corp. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $2,948; total assets went from $208,918 (2024-12-31) to $117.64 million (2025-12-31), a change of +56208.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2028735, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Silver Pegasus Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Silver Pegasus Acquisition Corp. (CIK 2028735) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-24. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Silver Pegasus Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-07-15.

Current reports. Of the 3 8-K or 6-K reports in Silver Pegasus Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2025-07-18 to 2025-09-05, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2028735 is on the EDGAR company page; the latest 10-K there is dated 2026-03-24 and the oldest filing in the recent index dates from 2024-07-15. Insider trades for Silver Pegasus Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Solarius capital acquisition corp. bullish and bearish analyst opinions

This section ties “Solarius capital acquisition corp. bullish and bearish analyst opinions” to Solarius Capital Acquisition Corp. (ticker SOCA, SOCAU, SOCAW), SEC Central Index Key 2065948, an EDGAR registrant classified as “Blank Checks” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-10-06. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-20 by Solarius Capital Acquisition Corp. (CIK 2065948) — source document:

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “business combination”). We have neither engaged in any operations nor generated any revenue to date. Based on our business activities, the Company is a “shell company” as defined under the Exchange Act of 1934 (the “Exchange Act”) because we have no operations and nominal assets consisting almost entirely of cash. Our efforts to identify a prospective initial business combination target will not be limited to a particular industry, sector or geographic region. While we may pursue an initial business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify and combine with a business or businesses that can benefit from our management team’s background and experience, including in the asset management, wealth management and financial services sectors.

Financial trend for Solarius Capital Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $630,309 (2025-09-30) to $1.36 million (2026-06-30), a change of +116.5%; total assets went from $175.68 million (2025-09-30) to $180.29 million (2026-06-30), a change of +2.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2065948, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Solarius Capital Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Solarius Capital Acquisition Corp. (CIK 2065948) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-20. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Solarius Capital Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 4 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-07-16.

Current reports. Of the 3 8-K or 6-K reports in Solarius Capital Acquisition Corp.’s recent EDGAR index, the 3 listed here run from 2025-07-18 to 2025-09-03, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2065948 is on the EDGAR company page; the latest 10-K there is dated 2026-03-20 and the oldest filing in the recent index dates from 2025-05-09. Insider trades for Solarius Capital Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tandy leather factory, inc. bullish and bearish analyst opinions

This section ties “Tandy leather factory, inc. bullish and bearish analyst opinions” to TANDY LEATHER FACTORY INC (ticker TLF), SEC Central Index Key 909724, an EDGAR registrant classified as “Leather & Leather Products” and organised in DE, formerly known as LEATHER FACTORY INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-08-11. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-24 by TANDY LEATHER FACTORY INC (CIK 909724) — source document:

MINE SAFETY DISCLOSURES 16 PART II 17 ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 17 ITEM 6. SELECTED FINANCIAL DATA 17 ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 17 ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 25 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 51 ITEM 9A. CONTROLS AND PROCEDURES 51 ITEM 9B. OTHER INFORMATION 52 PART III 52 ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE* 52 ITEM 11. EXECUTIVE COMPENSATION* 52 ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS* 52 ITEM 13.

Financial trend for TANDY LEATHER FACTORY INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $80.33 million (2022-12-31) to $76.32 million (2025-12-31), a change of -5.0%; net income (loss) went from $1.23 million (2022-12-31) to $9.10 million (2025-12-31), a change of +641.8%; total assets went from $68.58 million (2022-12-31) to $86.63 million (2025-12-31), a change of +26.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 909724, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures TANDY LEATHER FACTORY INC did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on TANDY LEATHER FACTORY INC (CIK 909724) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11, and the most recent 10-K annual report was filed 2026-02-24. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 193 8-K or 6-K reports in TANDY LEATHER FACTORY INC’s recent EDGAR index, the 4 listed here run from 2026-02-24 to 2026-08-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 909724 is on the EDGAR company page; the latest 10-K/A there is dated 2026-03-11 and the oldest filing in the recent index dates from 1996-05-10. Insider trades for TANDY LEATHER FACTORY INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Traws pharma, inc. bullish and bearish analyst opinions

This section ties “Traws pharma, inc. bullish and bearish analyst opinions” to Traws Pharma, Inc. (ticker TRAW), SEC Central Index Key 1130598, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as Onconova Therapeutics, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-04-15 by Traws Pharma, Inc. (CIK 1130598) — source document:

Traws Pharma, Inc. (“Traws,” “we,” or the “Company”) is a clinical stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. We are advancing novel investigational antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human health. Our product candidates are intended to be safe, with simple dosing regimens. We strive to utilize accelerated clinical trial strategies with a commitment to patients who are especially vulnerable. ​ On April 1, 2024, the Company (then known as Onconova Therapeutics, Inc.) consummated a merger (the “Merger”) with Trawsfynydd Therapeutics, Inc. (“Trawsfynydd”), a privately-held biotechnology company developing next-generation, best-in-class antivirals for influenza, COVID-19 and other infectious diseases.

Financial trend for Traws Pharma, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $226,000 (2022-12-31) to $2.79 million (2025-12-31), a change of +1134.5%; net income (loss) went from -$18.96 million (2022-12-31) to $9.17 million (2025-12-31), a change of +148.4%; total assets went from $39.37 million (2022-12-31) to $10.62 million (2025-12-31), a change of -73.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1130598, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Traws Pharma, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Traws Pharma, Inc. (CIK 1130598) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-14, and the most recent 10-K annual report was filed 2026-04-15. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 224 8-K or 6-K reports in Traws Pharma, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-10 to 2026-10-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1130598 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-30 and the oldest filing in the recent index dates from 2003-01-08. Insider trades for Traws Pharma, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Triplepoint venture growth bdc corp. bullish and bearish analyst opinions

This section ties “Triplepoint venture growth bdc corp. bullish and bearish analyst opinions” to TriplePoint Venture Growth BDC Corp. (ticker TPVG), SEC Central Index Key 1580345, an EDGAR registrant classified as “no SIC description” and organised in MD. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-15. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-04 by TriplePoint Venture Growth BDC Corp. (CIK 1580345) — source document:

We are an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company, or “BDC,” under the Investment Company Act of 1940, as amended, or the “1940 Act.” We have also elected to be treated, and intend to qualify annually, as a regulated investment company, or “RIC,” under Subchapter M of the Internal Revenue Code of 1986, as amended, or the “Code,” for U.S. federal income tax purposes. We were formed as a Maryland corporation on June 28, 2013 to expand the venture growth stage business segment of TPC’s investment platform. Our investment objective is to maximize our total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by lending, typically with warrants, primarily to venture growth stage companies focused in technology and other high growth industries backed by TPC’s select group of leading venture capital investors.

Financial trend for TriplePoint Venture Growth BDC Corp. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$20.07 million (2022-12-31) to $49.21 million (2025-12-31), a change of +345.2%; total assets went from $1.01 billion (2022-12-31) to $839.65 million (2025-12-31), a change of -17.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1580345, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures TriplePoint Venture Growth BDC Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on TriplePoint Venture Growth BDC Corp. (CIK 1580345) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-05, and the most recent 10-K annual report was filed 2026-03-04. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 117 8-K or 6-K reports in TriplePoint Venture Growth BDC Corp.’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-10-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1580345 is on the EDGAR company page; the latest 10-K there is dated 2026-03-04 and the oldest filing in the recent index dates from 2013-07-10. Insider trades for TriplePoint Venture Growth BDC Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Twfg, inc. common stock bullish and bearish analyst opinions

This section ties “Twfg, inc. common stock bullish and bearish analyst opinions” to TWFG, Inc. (ticker TWFG), SEC Central Index Key 2007596, an EDGAR registrant classified as “Insurance Agents, Brokers & Service” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-10 by TWFG, Inc. (CIK 2007596) — source document:

Who we are We are a leading, high-growth, independent distribution platform for personal and commercial insurance in the U.S. We are pioneers in the insurance industry, developing an agency model built on innovation and experience with what we believe is a more flexible approach than traditional distribution models. Our offerings are fulsome and flexible in that we offer all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate. Since our founding in 2001 by our Chief Executive Officer, Richard F. (“Gordy”) Bunch III, we have established a track record of creating solutions for independent agents, insurance carriers and our Clients, with growth regardless of economic and P&C pricing cycles.

Financial trend for TWFG, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $153.88 million (2022-12-31) to $248.51 million (2025-12-31), a change of +61.5%; net income (loss) went from $0 (2022-12-31) to $2.75 million (2024-12-31); total assets went from $115.44 million (2023-12-31) to $372.33 million (2025-12-31), a change of +222.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2007596, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures TWFG, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on TWFG, Inc. (CIK 2007596) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-05, and the most recent 10-K annual report was filed 2026-03-10. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 19 8-K or 6-K reports in TWFG, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-28 to 2026-08-13, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2007596 is on the EDGAR company page; the latest 10-K there is dated 2026-03-10 and the oldest filing in the recent index dates from 2024-01-19. Insider trades for TWFG, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Velos acquisition i corp. bullish and bearish analyst opinions

This section ties “Velos acquisition i corp. bullish and bearish analyst opinions” to Velos Acquisition I Corp. (ticker VLOS, VLOSU, VLOSW), SEC Central Index Key 2016072, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands, formerly known as M3-Brigade Acquisition V Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a S-1/A dated 2026-09-29. Nothing here is a recommendation to trade the security.

Financial trend for Velos Acquisition I Corp. from annual reports, periods 2024-12-31 to 2025-12-31: net income (loss) was tagged only for 2025-12-31 at $5.78 million; total assets went from $295.81 million (2024-12-31) to $308.18 million (2025-12-31), a change of +4.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2016072, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Velos Acquisition I Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Velos Acquisition I Corp. (CIK 2016072) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-02-17, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Velos Acquisition I Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 99 such filings (424B4, 425, DEFM14A, S-1, S-1/A) appear in its recent index, the newest dated 2026-09-29.

Current reports. Of the 14 8-K or 6-K reports in Velos Acquisition I Corp.’s recent EDGAR index, the 4 listed here run from 2026-06-10 to 2026-07-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2016072 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2024-04-18. Insider trades for Velos Acquisition I Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Xenetic biosciences, inc. bullish and bearish analyst opinions

This section ties “Xenetic biosciences, inc. bullish and bearish analyst opinions” to Xenetic Biosciences, Inc. (ticker XBIO), SEC Central Index Key 1534525, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in NV, formerly known as General Sales & Leasing, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-12 by Xenetic Biosciences, Inc. (CIK 1534525) — source document:

We are a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. Our proprietary DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (“NETs”), which are involved in cancer growth, metastasis and progression, and contribute to immunotherapy, chemotherapy and radiotherapy resistance. The DNase technology is designed to target NETs, which are weblike structures composed of extracellular chromatin coated with histones and other proteins. NETs are expelled by activated neutrophils in response to microbial or pro-inflammatory challenges. However, excessive production or reduced clearance of NETs can lead to aggravated inflammatory, hypercoagulability and autoimmune pathologies, as well as creation of pro-tumorigenic niches in the case of cancer growth and metastasis.

Financial trend for Xenetic Biosciences, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.71 million (2022-12-31) to $2.98 million (2025-12-31), a change of +74.4%; net income (loss) went from -$6.55 million (2022-12-31) to -$2.68 million (2025-12-31), a change of +59.1%; total assets went from $14.72 million (2022-12-31) to $8.36 million (2025-12-31), a change of -43.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1534525, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Xenetic Biosciences, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Xenetic Biosciences, Inc. (CIK 1534525) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-07, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 134 8-K or 6-K reports in Xenetic Biosciences, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-13 to 2026-09-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1534525 is on the EDGAR company page; the latest 10-K/A there is dated 2026-04-24 and the oldest filing in the recent index dates from 2011-11-21. Insider trades for Xenetic Biosciences, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

American patriot vanguard

What this search refers to. “American patriot vanguard” does not match a registered fund or company name; if it refers to an investment product, Investor.gov and FINRA BrokerCheck are the official places to confirm the seller is registered. Official source: adviserinfo.sec.gov.

No SEC filer could be matched to “American patriot vanguard” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “American patriot vanguard”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “american” (search terms considered: american, patriot, vanguard).

Word by word, the number of EDGAR registrant names containing each term of this search is: “american” 459, “patriot” 216, “vanguard” 170. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “american”: 1ST AMERICAN CREDIT CORP (CIK 1446528), 1ST AMERICAN NUCLEAR CO. (CIK 2074867), 3I NORTH AMERICAN INFRASTRUCTURE FUND A LP (CIK 1922071); containing “patriot”: ALL PRO PATRIOT PARK, LLLP (CIK 1769286), ALL PRO RETREAT AT PATRIOT PARK LLLP (CIK 1886907), ALTERITY PATRIOT PICKLEBALL SPV A SERIES OF CGF2021 LLC (CIK 2098719); containing “vanguard”: BRC VANGUARD CO-INVEST, LP (CIK 1694545), BRC VANGUARD PARALLEL CO-INVEST, LP (CIK 1694113), DEAL VANGUARD LTD (CIK 1767552). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Updated Oct 25, 2026 ET

Hemab therapeutics ceo news october 2026

This section ties “Hemab therapeutics ceo news october 2026” to Hemab Therapeutics Holdings, Inc. (ticker COAG), SEC Central Index Key 2114044, an EDGAR registrant classified as “Biological Products, (No Diagnostic Substances)” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-25, and this view starts from filings dated on or before 2026-04-30. Nothing here is a recommendation to trade the security.

Other filings. Across its 50 recent EDGAR filings, Hemab Therapeutics Holdings, Inc. most often filed 3 (12), 4 (10), SCHEDULE 13G (8), 8-K (5). A selection from 2026-05-06 to 2026-05-11:

The full record for CIK 2114044 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-02-27. One example from this record is the SCHEDULE 13G filed 2026-08-05 (document). Insider trades for Hemab Therapeutics Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Krakacquisition corp news

This section ties “Krakacquisition corp news” to KRAKacquisition Corp (ticker KRAQ, KRAQU, KRAQW), SEC Central Index Key 2082119, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-14, and this view starts from filings dated on or before 2026-02-02. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-30 by KRAKacquisition Corp (CIK 2082119) (passage 2, continuing from the earlier excerpt) — source document:

While we retain flexibility to pursue opportunities in any sector, we believe the most transformative opportunities lie in the convergence of DeFi and TradFi. We believe that our Sponsor’s deep expertise in these sectors will provide us with multiple opportunities in these sectors. We have reviewed, and continue to review, a number of opportunities to enter into a Business Combination, but we are unable to determine at this time whether we will complete a Business Combination with any of the target businesses that we have reviewed or with any other target business. We intend to effectuate our initial Business Combination using cash from the proceeds of our Initial Public Offering (as defined below) and the sale of the private placement shares, our shares, debt or a combination of cash, equity and debt.

For the latest news, the fastest official source is the filing feed: KRAKacquisition Corp (CIK 2082119) filed 3 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-03-19, and its overall latest filing is a SCHEDULE 13G/A dated 2026-08-14. Companies must file an 8-K within four business days of most material events.

Other filings. Across its 28 recent EDGAR filings, KRAKacquisition Corp most often filed 3 (9), SCHEDULE 13G (3), 8-K (3), 10-Q (2). A selection from 2026-01-27 to 2026-03-30:

The full record for CIK 2082119 is on the EDGAR company page; the latest 10-K there is dated 2026-03-30 and the oldest filing in the recent index dates from 2025-09-16. One example from this record is the SCHEDULE 13G filed 2026-05-13 (document). Insider trades for KRAKacquisition Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Rga international reinsurance company ltd. mobile apps

Apps tied to Rga international reinsurance company ltd. would be listed under its legal name as the developer or seller on Google Play and the Apple App Store. Those store listings, not the SEC, are the official source for what the firm publishes, its privacy disclosures and its support contacts; a store developer page is also the quickest way to tell a real company app from a look-alike.

No SEC filer could be matched to “Rga international reinsurance company ltd. mobile apps” with a single, clear Central Index Key: the phrase “Rga international reinsurance company ltd.” appears in 147+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “rga” (search terms considered: rga, international, reinsurance).

A broader EDGAR full-text search for the shorter phrase “Rga international reinsurance” finds 1212+ filing documents; among the top 100, the filers mentioning it most are REINSURANCE GROUP OF AMERICA INC (RGA, RZB, RZC) (CIK 0000898174) (34); METLIFE INVESTORS USA SEPARATE ACCOUNT A (CIK 0000356475) (12); METLIFE INVESTORS VARIABLE ANNUITY ACCOUNT ONE (CIK 0000815915) (9). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Rga international reinsurance company ltd.”, filings range from 2005-03-03 to 2009-03-02. The filers whose documents mention it most often are FIRST METLIFE INVESTORS VARIABLE ANNUITY ACCOUNT ONE (CIK 0000917952) (23 hits); METLIFE INVESTORS VARIABLE ANNUITY ACCOUNT ONE (CIK 0000815915) (20 hits); GENERAL AMERICAN SEPARATE ACCOUNT ELEVEN (CIK 0000806004) (12 hits); METLIFE INVESTORS VARIABLE LIFE ACCOUNT FIVE (CIK 0001047506) (8 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 8 entities whose registered name contains the word “rga”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “rga” 8, “international” 458, “reinsurance” 108. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Updated Oct 25, 2026 ET

Ton strategy tonx news october 2026

This section ties “Ton strategy tonx news october 2026” to TON Strategy Co (ticker TONX), SEC Central Index Key 1566610, an EDGAR registrant classified as “Finance Services” and organised in NV, formerly known as Verb Technology Company, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-16. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-31 by TON Strategy Co (CIK 1566610) — source document:

References in this document to the “Company,” “TON,” “we,” “us,” or “our” are intended to mean TON Strategy Company, individually, or as the context requires, collectively with its subsidiaries on a consolidated basis. TON Strategy Company is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain originally developed to integrate with Telegram, one of the world’s largest messaging platforms. The Open Network blockchain is designed to process transactions quickly and at scale, enabling a range of decentralized applications and digital services that can be accessed directly through Telegram’s global user base of more than one billion people. The Company’s core business is the management of its corporate treasury holdings of Toncoin (“TON” or “Toncoin”), the native digital asset of the TON blockchain.

Financial trend for TON Strategy Co from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$37.44 million (2022-12-31) to -$148.48 million (2025-12-31), a change of -296.6%; total assets went from $24.49 million (2022-12-31) to $411.16 million (2025-12-31), a change of +1578.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1566610, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures TON Strategy Co did not tag for that period.

For the latest news, the fastest official source is the filing feed: TON Strategy Co (CIK 1566610) filed 167 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-16, and its overall latest filing is a 8-K dated 2026-09-16. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 167 8-K or 6-K reports in TON Strategy Co’s recent EDGAR index, the 4 listed here run from 2026-08-10 to 2026-09-16, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1566610 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2013-01-10. Insider trades for TON Strategy Co appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Tungray technologies inc class a ordinary shares bullish and bearish analyst opinions

This section ties “Tungray technologies inc class a ordinary shares bullish and bearish analyst opinions” to Tungray Technologies Inc (ticker TRSG), SEC Central Index Key 1943444, an EDGAR registrant classified as “Construction, Mining & Materials Handling Machinery & Equip” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-04-23 by Tungray Technologies Inc (CIK 1943444) — source document:

Tungray is an exempted company incorporated with limited liability under the laws of the Cayman Islands on June 1, 2022 with operations conducted primarily through its Singapore Subsidiaries and PRC Subsidiaries. The Company is a holding company and is currently not actively engaging in any business. On June 21, 2022, Tungray established three wholly-owned subsidiaries under the laws of the BVI, Tungray Motion, Tungray Electronics and Tungray Intelligent, for the purpose of completing various reorganization transactions: · On November 22, 2022, Tungray acquired 100% of the issued and outstanding shares in Tungray Singapore, a Singapore private company limited by shares established on June 21, 2007, through Tungray Motion. Since May 27, 2010, Tungray Singapore, as the sole shareholder, established Tungray Industrial, a company established under the laws of the PRC on May 27, 2010, which owns 70% of the equity interests of Tongsheng Intelligent, a company established under the laws of the PRC on October 25, 2021 (while the other 30% owned by a PRC company of which Mr.

Financial trend for Tungray Technologies Inc from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $16.33 million (2022-12-31) to $15.62 million (2025-12-31), a change of -4.4%; net income (loss) went from $2.85 million (2022-12-31) to -$170,277 (2025-12-31), a change of -106.0%; total assets went from $26.03 million (2022-12-31) to $29.51 million (2025-12-31), a change of +13.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1943444, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Tungray Technologies Inc did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Tungray Technologies Inc (CIK 1943444) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 20-F annual report was filed 2026-04-23. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 18 8-K or 6-K reports in Tungray Technologies Inc’s recent EDGAR index, the 4 listed here run from 2026-08-18 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1943444 is on the EDGAR company page; the latest 20-F there is dated 2026-04-23 and the oldest filing in the recent index dates from 2022-12-16. Insider trades for Tungray Technologies Inc appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Albemarle tesla plug power intel partnership joint venture

Sample EDGAR registrant names, term by term — containing “albemarle”: ALBEMARLE MANAGEMENT FUND LP (CIK 1821327), ALBEMARLE SHOALS FUND, LLC (CIK 1855121), ALBEMARLE WODGINA PTY LTD (CIK 1814619); containing “tesla”: TESLA OFFSHORE L.L.C. (CIK 1288755), TESLA POWER & AUTOMATION LP (CIK 1085900), TESLA POWER GP INC (CIK 1085901); containing “plug”: PLUG DJ, INC. (CIK 1593482), PLUG DRINK, INC. (CIK 1943842), PLUG POWER INC (CIK 1093691); containing “power”: ABUNDANT POWER GROUP, LLC (CIK 1469560), ABUNDANT POWER SECURITIES, LLC (CIK 1284171), ACCELRATE POWER SYSTEMS INC. (CIK 1304658); containing “intel”: INTEL CAPITAL CORP (CIK 1129302), INTEL CORP (CIK 50863), INTEL FOUNDATION (CIK 1422503). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

Albemarle (lithium), Tesla (electric vehicles and storage), Plug Power (hydrogen fuel cells) and Intel (semiconductors) are four separate listed companies in different industries. A genuine joint venture between any two of them would have to be disclosed by each party that considers it material — normally in an 8-K under Item 1.01 (entry into a material definitive agreement) and later in the 10-K notes on equity-method investments. Searching each company’s own filing index for “joint venture” or “collaboration” is the reliable way to confirm or rule out a tie-up; press coverage that lumps the four names together is not evidence of a shared deal.

Updated Oct 25, 2026 ET

Albemarle tesla plug power intel strategic partnership

The undated form of the Albemarle, Tesla, Plug Power and Intel strategic-partnership search. Filing records below were read from EDGAR on Oct 25, 2026, one registrant per row.

PLUG POWER INC (PLUG; electrical industrial apparatus) — EDGAR lists the 8-K of 2026-03-10 covering 5.02 (departure/election of directors or officers); the 8-K of 2026-03-02 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits). Year to 2021-12-31: annual sales of $502.34 million, net result -$459.96 million (10-K, 2024-02-29).

ALBEMARLE CORP (ALB; plastic materials, synth resins & nonvulcan elastomers) filed the 8-K of 2026-03-25 covering 1.01 (entry into a material definitive agreement), 9.01 (financial statements and exhibits); the 8-K of 2026-03-06 covering 2.01 (completion of acquisition or disposition of assets), 7.01 (regulation fd disclosure), 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2021-12-31: FY revenue tagged at $3.33 billion, profit or loss $123.67 million (10-K, 2024-02-15).

Tesla, Inc. (TSLA; motor vehicles & passenger car bodies) filed the 8-K of 2026-01-02 covering 2.02 (results of operations and financial condition), 9.01 (financial statements and exhibits); the 8-K of 2025-11-07 covering 5.02 (departure/election of directors or officers), 5.07 (submission of matters to a vote of security holders), 9.01 (financial statements and exhibits). Year to 2021-12-31: FY revenue tagged at $53.82 billion, profit or loss $5.52 billion (10-K, 2024-01-29).

INTEL CORP (INTC; semiconductors & related devices) — EDGAR lists the 8-K of 2026-03-03 covering 7.01 (regulation fd disclosure), 8.01 (other events), 9.01 (financial statements and exhibits); the 8-K of 2026-01-23 covering 8.01 (other events), 9.01 (financial statements and exhibits). Year to 2021-12-25: annual sales of $79.02 billion, net result $19.87 billion (10-K, 2024-01-26).

How often each filed an 8-K under Item 2.02, results of operations and financial condition — the item that accompanies an earnings release: PLUG 50 (latest 2026-10-15), ALB 53 (latest 2026-08-05), TSLA 70 (latest 2026-10-21), INTC 31 (latest 2026-07-23).

Updated Oct 25, 2026 ET

Atlanticus holdings atlc latest news october 2026

This section ties “Atlanticus holdings atlc latest news october 2026” to Atlanticus Holdings Corp (ticker ATLC, ATLCL, ATLCP, ATLCZ), SEC Central Index Key 1464343, an EDGAR registrant classified as “Personal Credit Institutions” and organised in GA, formerly known as CompuCredit Holdings Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-06. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-12 by Atlanticus Holdings Corp (CIK 1464343) — source document:

This Report contains information that we obtained from industry and general publications and research, surveys and studies conducted by third parties. This information involves many assumptions and limitations, and you are cautioned not to give undue weight to any of this data. We have obtained this information from sources that we believe are reliable. However, we have not independently verified market or industry data from third party sources. General A general discussion of our business follows. Atlanticus is a financial technology company powering more inclusive financial solutions for Everyday Americans. We leverage data, analytics, and innovative technology to unlock access to financial solutions for the millions of Americans who would otherwise be underserved.

Financial trend for Atlanticus Holdings Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.05 billion (2022-12-31) to $1.97 billion (2025-12-31), a change of +88.0%; net income (loss) went from $135.60 million (2022-12-31) to $122.20 million (2025-12-31), a change of -9.9%; total assets went from $2.39 billion (2022-12-31) to $7.62 billion (2025-12-31), a change of +219.2%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1464343, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Atlanticus Holdings Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Atlanticus Holdings Corp (CIK 1464343) filed 76 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-06, and its overall latest filing is a 8-K dated 2026-10-06. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 76 8-K or 6-K reports in Atlanticus Holdings Corp’s recent EDGAR index, the 4 listed here run from 2025-09-17 to 2026-10-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1464343 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2009-05-22. Insider trades for Atlanticus Holdings Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Concrete pumping holdings bbcp latest news october 2026

This section ties “Concrete pumping holdings bbcp latest news october 2026” to Concrete Pumping Holdings, Inc. (ticker BBCP), SEC Central Index Key 1703956, an EDGAR registrant classified as “Construction - Special Trade Contractors” and organised in DE, formerly known as Industrea Acquisition Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-09-03. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-01-13 by Concrete Pumping Holdings, Inc. (CIK 1703956) — source document:

Concrete Pumping Holdings, Inc. is a Delaware corporation headquartered in Thornton, Colorado. We refer to Concrete Pumping Holdings, Inc. as the "Company," "CPH,", "us", "we" or "our" in this Annual Report, and these designations include our subsidiaries unless we state otherwise. Our principal executive offices are located at 500 E. 84 th Ave., Suite A-5, Thornton, Colorado, 80229. We maintain a website at https://www.concretepumpingholdings.com/ . The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this Annual Report. Overview CPH is a leading provider of concrete pumping services and concrete waste management services in the United States ("U.S.") and the United Kingdom ("U.K.") based on fleet size, primarily operating under what we believe are the only established, national concrete pumping brands in both geographies – Brundage-Bone Concrete Pumping, Inc. ("Brundage-Bone") for concrete pumping in the U.S., Camfaud Group Limited ("Camfaud") in the U.K., and Eco-Pan, Inc. ("Eco-Pan") for waste management services in both the U.S. and U.K. The Brundage-Bone business was founded in 1983 in Denver, Colorado.

Financial trend for Concrete Pumping Holdings, Inc. from annual reports, periods 2022-10-31 to 2025-10-31: revenue went from $401.29 million (2022-10-31) to $392.87 million (2025-10-31), a change of -2.1%; net income (loss) went from $28.68 million (2022-10-31) to $6.37 million (2025-10-31), a change of -77.8%; total assets went from $887.49 million (2022-10-31) to $879.54 million (2025-10-31), a change of -0.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1703956, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Concrete Pumping Holdings, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Concrete Pumping Holdings, Inc. (CIK 1703956) filed 78 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-03, and its overall latest filing is a 10-Q dated 2026-09-03. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 78 8-K or 6-K reports in Concrete Pumping Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2026-04-01 to 2026-09-03, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1703956 is on the EDGAR company page; the latest 10-K there is dated 2026-01-13 and the oldest filing in the recent index dates from 2017-05-03. Insider trades for Concrete Pumping Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Legato merger iv (lego) news october 2026

This section ties “Legato merger iv (lego) news october 2026” to Legato Merger Corp. IV (ticker LEGO, LEGO-UN, LEGO-WT), SEC Central Index Key 2087450, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-08-05, and this view starts from filings dated on or before 2026-03-04. Nothing here is a recommendation to trade the security.

Financial trend for Legato Merger Corp. IV from quarterly and annual reports (three-month periods), periods 2025-11-30 to 2026-05-31: net income (loss) went from -$33,756 (2025-11-30) to $1.79 million (2026-05-31), a change of +5397.6%; total assets went from $70,535 (2025-11-30) to $234.92 million (2026-05-31), a change of +332947.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2087450, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Legato Merger Corp. IV did not tag for that period.

For the latest news, the fastest official source is the filing feed: Legato Merger Corp. IV (CIK 2087450) filed 3 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-05, and its overall latest filing is a 8-K dated 2026-08-05. Companies must file an 8-K within four business days of most material events.

Deal and listing documents for Legato Merger Corp. IV — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B3, S-1, S-1/A) appear in its recent index, the newest dated 2026-01-26.

Other filings. Across its 31 recent EDGAR filings, Legato Merger Corp. IV most often filed 3 (9), 4 (7), 8-K (3), 10-Q (3). A selection from 2026-03-04 to 2026-07-08:

The full record for CIK 2087450 is on the EDGAR company page and the oldest filing in the recent index dates from 2025-10-14. One example from this record is the 4 filed 2026-08-04 (document). Insider trades for Legato Merger Corp. IV appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nucana

This section ties “Nucana” to NuCana plc (ticker NCNA), SEC Central Index Key 1709626, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in United Kingdom, formerly known as NuCana BioMed Ltd. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 6-K dated 2026-09-30. Nothing here is a recommendation to trade the security.

Business description, quoted from the 20-F filed 2026-03-19 by NuCana plc (CIK 1709626) — source document:

Operating and Financial Review and Prospects 103 A. Operating Results 103 B. Liquidity and Capital Resources 108 C. Research and Development, Patents and Licenses, etc. 110 D. Trend Information 110 E. Critical Accounting Estimates 110 F. [Reserved] 110 G. [Reserved] 110 H. Non-GAAP Financial Measures 110 Item 6. Directors, Senior Management and Employees 111 A. Directors and Senior Management 111 B. Compensation 113 C. Board Practices 120 D. Employees 121 E. Share Ownership 122 F. Disclosure of a Registrant's Action to Recover Erroneously Awarded Compensation 122 Item 7. Major Shareholders and Related Party Transactions 122 A. Major Shareholders 122 B. Related Party Transactions 123 C. Interests of Experts and Counsel 124 Item 8.

Financial trend for NuCana plc from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -32,021,000 GBP (2022-12-31) to -29,353,000 GBP (2025-12-31), a change of +8.3%; total assets went from 58,254,000 GBP (2022-12-31) to 29,834,000 GBP (2025-12-31), a change of -48.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1709626, tags Assets, ProfitLoss; 4 periods shown, dashes mark figures NuCana plc did not tag for that period.

NuCana plc has 282 filings in its recent EDGAR index, including 9 annual reports and 0 quarterly reports; its newest filing is a 6-K from 2026-09-30.

Current reports. Of the 137 8-K or 6-K reports in NuCana plc’s recent EDGAR index, the 4 listed here run from 2026-06-01 to 2026-09-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1709626 is on the EDGAR company page; the latest 20-F there is dated 2026-03-19 and the oldest filing in the recent index dates from 2017-06-26. Insider trades for NuCana plc appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Pfizer rocky mount nc

This section ties “Pfizer rocky mount nc” to PFIZER INC (ticker PFE), SEC Central Index Key 78003, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as PFIZER INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-16. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-26 by PFIZER INC (CIK 78003) — source document:

MINE SAFETY DISCLOSURES N/A INFORMATION ABOUT OUR EXECUTIVE OFFICERS 27 PART II 29 ITEM 5. MARKET FOR THE COMPANY’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 29 ITEM 6. [RESERVED] 29 ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 30 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 49 ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 50 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 103 ITEM 9A. CONTROLS AND PROCEDURES 104 ITEM 9B. OTHER INFORMATION 107 ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS N/A PART III 107 ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 107 ITEM 11.

Financial trend for PFIZER INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $101.17 billion (2022-12-31) to $62.58 billion (2025-12-31), a change of -38.1%; net income (loss) went from $31.37 billion (2022-12-31) to $7.77 billion (2025-12-31), a change of -75.2%; total assets went from $197.21 billion (2022-12-31) to $208.16 billion (2025-12-31), a change of +5.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 78003, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures PFIZER INC did not tag for that period.

PFIZER INC has 1000 filings in its recent EDGAR index, including 6 annual reports and 17 quarterly reports; its newest filing is a 4 from 2026-10-16.

Current reports. Of the 59 8-K or 6-K reports in PFIZER INC’s recent EDGAR index, the 4 listed here run from 2026-05-05 to 2026-08-04, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 78003 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2021-02-23. Insider trades for PFIZER INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Spectral ai mdai latest news october 2026 earnings product

This section ties “Spectral ai mdai latest news october 2026 earnings product” to Spectral AI, Inc. (ticker MDAI, MDAIW), SEC Central Index Key 1833498, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in DE, formerly known as Rosecliff Acquisition Corp I. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-29, and this view starts from filings dated on or before 2026-06-29. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-25 by Spectral AI, Inc. (CIK 1833498) (passage 2, continuing from the earlier excerpt) — source document:

The UKCA marking registration was fully completed on March 7, 2024. In 2026, we hope that our full DeepView System may achieve Class II medical device designation with the United States Food and Drug Administration (FDA) via the De Novo application the Company submitted in June of 2025. Subject to our receipt of additional necessary market authorization, our business will have two revenue streams, a SaaS (software as a service) model component predicated on utilizing the regulatory method, a SaMD (software as a medical device) regulatory framework, and the imaging device component. The SaaS component will feature a software licensing fee that includes maintenance, image hosting, and access to algorithmic updates.

Financial trend for Spectral AI, Inc. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: revenue went from $3.79 million (2025-09-30) to $3.52 million (2026-06-30), a change of -7.1%; net income (loss) went from -$3.55 million (2025-09-30) to -$4.18 million (2026-06-30), a change of -17.6%; total assets went from $15.30 million (2025-09-30) to $19.44 million (2026-06-30), a change of +27.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1833498, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Spectral AI, Inc. did not tag for that period.

For reported results, Spectral AI, Inc.’s (CIK 1833498) latest 10-Q is dated 2026-08-11 and its latest annual report (10-K) 2026-03-25. Earnings releases appear as 8-K Item 2.02 filings; 7 are in the recent index, the newest on 2026-08-12.

Current reports. Of the 65 8-K or 6-K reports in Spectral AI, Inc.’s recent EDGAR index, the 4 listed here run from 2026-03-25 to 2026-05-26, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1833498 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2020-12-23. One example from this record is the 4 filed 2026-09-14 (document). Insider trades for Spectral AI, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Xenia hotels resorts xhr news october 2026

This section ties “Xenia hotels resorts xhr news october 2026” to Xenia Hotels & Resorts, Inc. (ticker XHR), SEC Central Index Key 1616000, an EDGAR registrant classified as “Hotels & Motels” and organised in FL. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-15. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-24 by Xenia Hotels & Resorts, Inc. (CIK 1616000) — source document:

Xenia Hotels & Resorts, Inc. is a Maryland corporation that primarily invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States ("U.S."). Substantially all of the Company's assets are held by, and all the operations are conducted through XHR LP (the "Operating Partnership"). XHR GP, Inc. is the sole general partner of the Operating Partnership and is wholly-owned by the Company. As of December 31, 2025, the Company collectively owned 94.4% of the common limited partnership units issued by the Operating Partnership ("Operating Partnership Units"). The remaining 5.6% of the Operating Partnership Units are owned by the other limited partners comprised of certain of our executive officers and current or former members of our Board of Directors and includes vested and unvested long-term incentive plan ("LTIP") partnership units.

Financial trend for Xenia Hotels & Resorts, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $997.61 million (2022-12-31) to $1.08 billion (2025-12-31), a change of +8.1%; net income (loss) went from $55.92 million (2022-12-31) to $63.09 million (2025-12-31), a change of +12.8%; total assets went from $3.08 billion (2022-12-31) to $2.81 billion (2025-12-31), a change of -8.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1616000, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Xenia Hotels & Resorts, Inc. did not tag for that period.

For the latest news, the fastest official source is the filing feed: Xenia Hotels & Resorts, Inc. (CIK 1616000) filed 115 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-09-15, and its overall latest filing is a 8-K dated 2026-09-15. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 115 8-K or 6-K reports in Xenia Hotels & Resorts, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-09-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1616000 is on the EDGAR company page; the latest 10-K there is dated 2026-02-24 and the oldest filing in the recent index dates from 2014-08-11. Insider trades for Xenia Hotels & Resorts, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Abony acquisition i a (aaco) news october 2026

This section ties “Abony acquisition i a (aaco) news october 2026” to Abony Acquisition Corp. I (ticker AACO, AACOU, AACOW), SEC Central Index Key 2099906, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-11. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by Abony Acquisition Corp. I (CIK 2099906) — source document:

We are a blank check company incorporated on November 13, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Report as our initial business combination. While we may pursue an initial business combination target in any industry or geographic region, we intend to focus on companies that have an aggregate enterprise value of approximately $750 million to $1.5 billion or more, that complement our management team’s background in defense technology, advanced computing, software and media industry sectors. We believe that the operational, investment and capital markets experience of our management team will make us an attractive partner to potential target businesses, enhance our ability to complete a successful business combination, and bring value to the target post-business combination.

Financial trend for Abony Acquisition Corp. I from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from $546,079 (2026-03-31) to $1.84 million (2026-06-30), a change of +237.4%; total assets went from $232.35 million (2026-03-31) to $234.20 million (2026-06-30), a change of +0.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2099906, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures Abony Acquisition Corp. I did not tag for that period.

For the latest news, the fastest official source is the filing feed: Abony Acquisition Corp. I (CIK 2099906) filed 3 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-04-08, and its overall latest filing is a 10-Q dated 2026-08-11. Companies must file an 8-K within four business days of most material events.

Deal and listing documents for Abony Acquisition Corp. I — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-02-19.

Current reports. Of the 3 8-K or 6-K reports in Abony Acquisition Corp. I’s recent EDGAR index, the 3 listed here run from 2026-02-20 to 2026-04-08, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2099906 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2025-12-29. Insider trades for Abony Acquisition Corp. I appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Cartesian therapeutics descartes-08 october 2026 news

This section ties “Cartesian therapeutics descartes-08 october 2026 news” to Cartesian Therapeutics, Inc. (ticker RNAC), SEC Central Index Key 1453687, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as SELECTA BIOSCIENCES INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-29, and this view starts from filings dated on or before 2026-03-13. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-09 by Cartesian Therapeutics, Inc. (CIK 1453687) (passage 3, continuing from the earlier excerpt) — source document:

Autoimmune diseases, where the immune system mistakenly attacks the body, are a family of more than 80 disorders. These diseases are typically treated with immunosuppressant medications, such as steroids, biologics and non-steroidal agents such as methotrexate, CD19 directed therapies and intravenous immunoglobulin. These treatments must be administered chronically and carry risks, including infection, osteoporosis and metabolic disease. The treatment landscape within generalized myasthenia gravis, or MG, offers agents that block the complement pathway or inhibit the neonatal Fc receptor, or FcRn, that typically must be administered chronically. Even with recent treatment advancements in the field of MG, we believe there remains a significant unmet need for outpatient treatments, administered over a short period of time, and can provide deep and durable clinical benefit.

Financial trend for Cartesian Therapeutics, Inc. from annual reports, periods 2018-12-31 to 2021-12-31: net income (loss) went from -$65.34 million (2018-12-31) to -$25.69 million (2021-12-31), a change of +60.7%; total assets went from $44.48 million (2018-12-31) to $159.88 million (2021-12-31), a change of +259.4%. Values are as filed and not adjusted for restatements, splits or currency.

Current reports. Of the 172 8-K or 6-K reports in Cartesian Therapeutics, Inc.’s recent EDGAR index, the 4 listed here run from 2025-11-06 to 2026-01-09, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1453687 is on the EDGAR company page; the latest 10-K there is dated 2026-03-09 and the oldest filing in the recent index dates from 2009-01-05. One example from this record is the 8-K filed 2026-06-09 (document). Insider trades for Cartesian Therapeutics, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Aflac ventures llc mobile apps

This section ties “Aflac ventures llc mobile apps” to AFLAC INC (ticker AFL), SEC Central Index Key 4977, an EDGAR registrant classified as “Accident & Health Insurance” and organised in GA. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-25 by AFLAC INC (CIK 4977) — source document:

Aflac Incorporated and its subsidiaries (the Company) desire to take advantage of these provisions. This report contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with or furnished to the Securities and Exchange Commission (SEC). Business ITEM 1. BUSINESS OVERVIEW Aflac Incorporated (the Parent Company) was incorporated in 1973 under the laws of the state of Georgia. The Parent Company and its subsidiaries (collectively, the Company) provide financial protection to millions of policyholders and customers in Japan and the United States (U.S.).

Financial trend for AFLAC INC from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $19.14 billion (2022-12-31) to $17.16 billion (2025-12-31), a change of -10.3%; net income (loss) went from $4.42 billion (2022-12-31) to $3.65 billion (2025-12-31), a change of -17.5%; total assets went from $131.74 billion (2022-12-31) to $116.47 billion (2025-12-31), a change of -11.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 4977, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures AFLAC INC did not tag for that period.

The search also names a website or app. Product logins, apps and web pages are run by the company, not the SEC; the EDGAR record for AFLAC INC (CIK 4977) lists its business address as 1932 WYNNTON RD, COLUMBUS, GA, which helps confirm you are on the right company’s site.

Current reports. Of the 101 8-K or 6-K reports in AFLAC INC’s recent EDGAR index, the 4 listed here run from 2026-05-14 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 4977 is on the EDGAR company page; the latest 10-K there is dated 2026-02-25 and the oldest filing in the recent index dates from 2017-02-28. Insider trades for AFLAC INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Netscout pfs fabric manager cve

Also searched as: pfs fabric manager cve netscout

This section ties “Netscout pfs fabric manager cve” to NETSCOUT SYSTEMS INC (ticker NTCT), SEC Central Index Key 1078075, an EDGAR registrant classified as “Services-Computer Integrated Systems Design” and organised in DE, formerly known as NETSCOUT SYSTEMS INC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-14. Nothing here is a recommendation to trade the security.

Vulnerability records for NetScout PFS Fabric Manager. Security flaws are catalogued by the U.S. National Vulnerability Database (NVD), run by NIST, not by the SEC. A keyword query of the NVD on Oct 25, 2026 returned 42 CVE entries whose descriptions mention NetScout PFS Fabric Manager; 0 of them were published in 2026, and the newest overall is CVE-2025-32986 from 2025-04-25. Severity scores below are the CVSS base scores NVD lists; vendor advisories give fixed versions.

Financial trend for NETSCOUT SYSTEMS INC from annual reports, periods 2023-03-31 to 2026-03-31: net income (loss) went from $59.65 million (2023-03-31) to $95.53 million (2026-03-31), a change of +60.2%; total assets went from $2.82 billion (2023-03-31) to $2.35 billion (2026-03-31), a change of -16.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1078075, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures NETSCOUT SYSTEMS INC did not tag for that period.

Current reports. Of the 96 8-K or 6-K reports in NETSCOUT SYSTEMS INC’s recent EDGAR index, the 4 listed here run from 2026-05-07 to 2026-09-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1078075 is on the EDGAR company page; the latest 10-K there is dated 2026-05-14 and the oldest filing in the recent index dates from 2013-01-17. Insider trades for NETSCOUT SYSTEMS INC appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

PFS Fabric Manager is the management software for NETSCOUT’s packet-flow switch fabric; issues affecting it are typically web-interface flaws in the management console. Restricting the console to a management network reduces exposure while a fixed version is scheduled.

Newel auctions leadership jake baer news

Also searched as: newel auctions jake baer leadership news

What this search refers to. Newel is a privately held New York antiques and auction house; leadership news about Jake Baer and the business is published by the company itself, because a private firm files no 8-K reports. Official source: www.newel.com.

No SEC filer could be matched to “Newel auctions leadership jake baer news” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Newel auctions leadership jake baer”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “newel” (search terms considered: newel, auctions, leadership, jake, baer).

Even the shorter phrase “Newel auctions jake” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (newel, auctions, leadership, jake, baer) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 1 entities whose registered name contains the word “newel”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “newel” 1, “auctions” 11, “leadership” 30, “jake” 37, “baer” 58. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “newel”: NEWEL CORP (CIK 1911489); containing “auctions”: AAMG TAX AUCTIONS, LLC (CIK 2092710), ACV AUCTIONS INC. (CIK 1637873), COIN & CARD AUCTIONS, INC (CIK 1923088); containing “leadership”: AFRICAN LEADERSHIP (MAURITIUS) LTD (CIK 1671889), ARETE LEADERSHIP GROUP, INC. (CIK 2108429), ASPEN LEADERSHIP GROUP, LLC (CIK 1617821); containing “jake”: BAUER JAKE (CIK 1654909), BERGMANN R. JAKE (CIK 1729224), CARNEY PATRICK JAKE (CIK 2146456); containing “baer”: BAER & CO LLC /BD (CIK 714552), BAER ALAN E. (CIK 1484371), BAER ARTHUR D. (CIK 1832240). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: for recent news on “newel”, use the company’s own press releases or its home-exchange announcements, since there is no SEC 8-K feed for a non-filer. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Spectral ai press release latest mdai

Also searched as: spectral ai latest press release mdai; spectral ai mdai press release latest

This section ties “Spectral ai press release latest mdai” to Spectral AI, Inc. (ticker MDAI, MDAIW), SEC Central Index Key 1833498, an EDGAR registrant classified as “Surgical & Medical Instruments & Apparatus” and organised in DE, formerly known as Rosecliff Acquisition Corp I. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-09-29, and this view starts from filings dated on or before 2025-10-30. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-25 by Spectral AI, Inc. (CIK 1833498) (passage 5, continuing from the earlier excerpt) — source document:

Our DeepView System’s proprietary optics can extract millions of pixels of data or AI model features from each group of raw images. This information is then used to advance the algorithm optimization, which is trained and tested against a proprietary and clinically validated database of over 340 billion pixels of image data. The DeepView-AI Burns ® software is used with the DeepView SnapShot ® imaging device, and it is intended to be used as an adjunctive tool to aid health care providers in the assessment of burn wound healing potential by differentiating non-healing from healing tissue within an image. Below at Figure 1 is an example of the DeepView System technological process.

Financial trend for Spectral AI, Inc. from quarterly and annual reports (three-month periods), periods 2023-09-30 to 2024-06-30: revenue went from $3.44 million (2023-09-30) to $7.48 million (2024-06-30), a change of +117.4%; net income (loss) went from -$10.63 million (2023-09-30) to -$2.86 million (2024-06-30), a change of +73.1%; total assets went from $12.33 million (2023-09-30) to $13.90 million (2024-06-30), a change of +12.7%. Values are as filed and not adjusted for restatements, splits or currency.

Current reports. Of the 65 8-K or 6-K reports in Spectral AI, Inc.’s recent EDGAR index, the 4 listed here run from 2025-04-02 to 2025-05-30, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1833498 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2020-12-23. One example from this record is the 4 filed 2026-05-27 (document). Insider trades for Spectral AI, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Acurx pharmaceuticals, inc. bullish and bearish analyst opinions

This section ties “Acurx pharmaceuticals, inc. bullish and bearish analyst opinions” to Acurx Pharmaceuticals, Inc. (ticker ACXP), SEC Central Index Key 1736243, an EDGAR registrant classified as “Pharmaceutical Preparations” and organised in DE, formerly known as Acurx Pharmaceuticals, LLC. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-16. Nothing here is a recommendation to trade the security.

Financial trend for Acurx Pharmaceuticals, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$12.09 million (2022-12-31) to -$7.97 million (2025-12-31), a change of +34.1%; total assets went from $9.38 million (2022-12-31) to $7.69 million (2025-12-31), a change of -18.0%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1736243, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Acurx Pharmaceuticals, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Acurx Pharmaceuticals, Inc. (CIK 1736243) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2025-05-13, and the most recent 10-K annual report was filed 2026-03-12. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 37 8-K or 6-K reports in Acurx Pharmaceuticals, Inc.’s recent EDGAR index, the 4 listed here run from 2025-09-22 to 2026-10-16, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 244 recent EDGAR filings, Acurx Pharmaceuticals, Inc. most often filed 4 (51), 8-K (37), 10-Q (16), EFFECT (14). A selection from 2026-09-01 to 2026-09-17:

The full record for CIK 1736243 is on the EDGAR company page; the latest 10-K there is dated 2026-03-12 and the oldest filing in the recent index dates from 2018-04-03. Insider trades for Acurx Pharmaceuticals, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Airship ai holdings sec filing october 2026

This section ties “Airship ai holdings sec filing october 2026” to Airship AI Holdings, Inc. (ticker AISP, AISPW), SEC Central Index Key 1842566, an EDGAR registrant classified as “Services-Prepackaged Software” and organised in DE, formerly known as BYTE Acquisition Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a PRE 14A dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-17 by Airship AI Holdings, Inc. (CIK 1842566) — source document:

Airship AI Holdings, Inc. (the “Company” or “Airship”) is a holding company incorporated in Delaware that executes business through its wholly owned subsidiary, Airship AI, Inc. (“Airship AI”). Prior to the formation of Super Simple AI, Inc. in 2022, the Company operated as Airship AI, Inc. (formerly known as JDL Digital Systems, Inc.). JDL Digital Systems, Inc. was incorporated under the laws of the State of Washington on June 30, 2003. Super Simple AI, Inc. was formed in January 2022 through a share exchange with JDL Digital Systems, Inc. On March 7, 2023, Super Simple AI, Inc. changed its name to Airship AI Holdings, Inc. On December 21, 2023, the Company completed the merger contemplated by the Merger Agreement, dated as of June 27, 2023, as amended (the “Merger Agreement”) by and among BYTE Acquisition Corp. (“BYTS”), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of BYTS (“Merger Sub”), and Airship AI. Effective December 21, 2023, Merger Sub merged with and into Airship AI with Airship AI as the surviving corporation (the “merger”).

Financial trend for Airship AI Holdings, Inc. from annual reports, periods 2023-12-21 to 2025-12-31: revenue went from $12.30 million (2023-12-31) to $15.32 million (2025-12-31), a change of +24.6%; net income (loss) went from $16.37 million (2023-12-21) to $29.32 million (2025-12-31), a change of +79.1%; total assets went from $6.09 million (2023-12-31) to $19.48 million (2025-12-31), a change of +219.9%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1842566, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Airship AI Holdings, Inc. did not tag for that period.

Airship AI Holdings, Inc. has 324 filings in its recent EDGAR index, including 5 annual reports and 17 quarterly reports; its newest filing is a PRE 14A from 2026-10-19.

Current reports. Of the 50 8-K or 6-K reports in Airship AI Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2025-12-12 to 2026-08-06, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1842566 is on the EDGAR company page; the latest 10-K there is dated 2026-02-17 and the oldest filing in the recent index dates from 2021-02-03. Insider trades for Airship AI Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Aosl alpha omega semiconductor press release october 2026

This section ties “Aosl alpha omega semiconductor press release october 2026” to ALPHA & OMEGA SEMICONDUCTOR Ltd (ticker AOSL), SEC Central Index Key 1387467, an EDGAR registrant classified as “Semiconductors & Related Devices” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a ARS dated 2026-09-30. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-08-27 by ALPHA & OMEGA SEMICONDUCTOR Ltd (CIK 1387467) — source document:

You should read this Annual Report on Form 10-K in its entirety and with the understanding that our actual future results may be materially different from what we expect. Overview We are a designer, developer and global supplier of a broad portfolio of power semiconductors. Our portfolio of power semiconductors includes approximately 2,900 products, and has grown with the introduction of over 70 new products in the fiscal year ended June 30, 2026, and over 100 new products in each of the fiscal years ended June 30, 2025 and 2024, respectively. Our teams of scientists and engineers have developed extensive intellectual properties and technical knowledge that encompass major aspects of power semiconductors, which we believe enables us to introduce and develop innovative products to address the increasingly complex power requirements of advanced electronics.

Financial trend for ALPHA & OMEGA SEMICONDUCTOR Ltd from annual reports, periods 2023-06-30 to 2026-06-30: net income (loss) went from $12.36 million (2023-06-30) to -$42.27 million (2026-06-30), a change of -441.8%; total assets went from $1.20 billion (2023-06-30) to $963.55 million (2026-06-30), a change of -19.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1387467, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures ALPHA & OMEGA SEMICONDUCTOR Ltd did not tag for that period.

For the latest news, the fastest official source is the filing feed: ALPHA & OMEGA SEMICONDUCTOR Ltd (CIK 1387467) filed 142 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-08-12, and its overall latest filing is a ARS dated 2026-09-30. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 142 8-K or 6-K reports in ALPHA & OMEGA SEMICONDUCTOR Ltd’s recent EDGAR index, the 4 listed here run from 2026-05-06 to 2026-08-12, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1387467 is on the EDGAR company page; the latest 10-K there is dated 2026-08-27 and the oldest filing in the recent index dates from 2007-01-16. Insider trades for ALPHA & OMEGA SEMICONDUCTOR Ltd appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Armata pharmaceuticals, inc. bullish and bearish analyst opinions

This section ties “Armata pharmaceuticals, inc. bullish and bearish analyst opinions” to Armata Pharmaceuticals, Inc. (ticker ARMP), SEC Central Index Key 921114, an EDGAR registrant classified as “Biological Products, (No Diagnostic Substances)” and organised in WA, formerly known as AmpliPhi Biosciences Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-23. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-25 by Armata Pharmaceuticals, Inc. (CIK 921114) — source document:

We are a late clinical-stage biotechnology company focused on the development of high-purity and potency, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using our proprietary bacteriophage-based technology. We have completed three Phase 2 clinical trials to date. ​ We see bacteriophages as a potentially safer and effective alternative to antibiotics and an essential response to the growing bacterial resistance to current classes of antibiotics. Bacteriophages or “phages” have a powerful and highly differentiated mechanism of action that enables binding to and killing of specific targeted bacteria while uniquely preserving the normal human microbiome or “healthy bacteria”. This is in direct contrast to traditional broad-spectrum antibiotics which can alter the human microbiome increasing susceptibility to opportunistic pathogens, such as Clostridium difficile . We believe that phages represent a promising means to effectively treat bacterial infections as an alternative to broad-spectrum antibiotics, especially for patients with bacterial infections resistant to current standard of care therapies, including the multidrug-resistant or “superbug” strains of bacteria.

Financial trend for Armata Pharmaceuticals, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$36.92 million (2022-12-31) to -$173.80 million (2025-12-31), a change of -370.8%; total assets went from $95.83 million (2022-12-31) to $76.88 million (2025-12-31), a change of -19.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 921114, tags Assets, NetIncomeLoss; 4 periods shown, dashes mark figures Armata Pharmaceuticals, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Armata Pharmaceuticals, Inc. (CIK 921114) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-12, and the most recent 10-K annual report was filed 2026-03-25. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 282 8-K or 6-K reports in Armata Pharmaceuticals, Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-20 to 2026-09-23, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 921114 is on the EDGAR company page; the latest 10-K there is dated 2026-03-25 and the oldest filing in the recent index dates from 2004-01-27. Insider trades for Armata Pharmaceuticals, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Bounty oil & gas nl bullish and bearish analyst opinions

Read from its name, “Bounty oil & gas nl” is a Australia entity — “NL” (no liability) is an Australian company form historically used by mining explorers. Its accounts and exchange notices are published through ASX company announcements (www.asx.com.au); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Bounty oil & gas nl bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Bounty oil & gas nl” appears in 21 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “bounty” (search terms considered: bounty, oil, gas).

A broader EDGAR full-text search for the shorter phrase “Bounty oil gas” finds 26 filing documents; among the top 26, the filers mentioning it most are SUMMIT EXPLORATION INC. (CIK 0001357642) (8); SENTRY PETROLEUM LTD. (CIK 0001357642) (8); Pelican Holdco, Inc. (CIK 0002093507) (5). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 21 most relevant full-text hits returned for “Bounty oil & gas nl”, filings range from 2006-05-11 to 2026-02-18. The filers whose documents mention it most often are SUMMIT EXPLORATION INC. (CIK 0001357642) (8 hits); SENTRY PETROLEUM LTD. (CIK 0001357642) (8 hits); Pelican Holdco, Inc. (CIK 0002093507) (5 hits); Greenland Exploration Ltd (CIK 0002094400) (5 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 18 entities whose registered name contains the word “bounty”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “bounty” 18, “oil” 481, “gas” 471. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “bounty” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Callan jmb inc. bullish and bearish analyst opinions

This section ties “Callan jmb inc. bullish and bearish analyst opinions” to CALLAN JMB INC. (ticker CJMB), SEC Central Index Key 2032545, an EDGAR registrant classified as “Services-Business Services, NEC” and organised in NV. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a POS AM dated 2026-10-20. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-31 by CALLAN JMB INC. (CIK 2032545) — source document:

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility. We view our solutions as disruptive to the “older technologies” of dry ice and liquid nitrogen, in that our solutions are comprehensive and combine our competencies in configurations that are customized to our client’s requirements.

Financial trend for CALLAN JMB INC. from annual reports, periods 2023-12-31 to 2025-12-31: revenue went from $13.20 million (2023-12-31) to $5.72 million (2025-12-31), a change of -56.7%; net income (loss) went from $2.18 million (2023-12-31) to -$7.97 million (2025-12-31), a change of -465.2%; total assets went from $9.71 million (2023-12-31) to $5.78 million (2025-12-31), a change of -40.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2032545, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures CALLAN JMB INC. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on CALLAN JMB INC. (CIK 2032545) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-03-31, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 21 8-K or 6-K reports in CALLAN JMB INC.’s recent EDGAR index, the 4 listed here run from 2026-08-31 to 2026-10-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2032545 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2024-08-05. Insider trades for CALLAN JMB INC. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Claritev ctev latest news october 2026

This section ties “Claritev ctev latest news october 2026” to Claritev Corp (ticker CTEV), SEC Central Index Key 1793229, an EDGAR registrant classified as “Services-Business Services, NEC” and organised in DE, formerly known as MultiPlan Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 4 dated 2026-10-19. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-26 by Claritev Corp (CIK 1793229) — source document:

Claritev brings objective, market-based insights to some of the healthcare system's most complex decisions - grounded in decades of claims experience. By applying data, analytics and experience, Claritev helps organizations across the healthcare ecosystem better understand costs, pricing and payment dynamics. This clarity enables more informed decision-making, reduces friction and improves how the healthcare system functions in service of greater affordability, alignment and long-term sustainability. Founded in 1980, Claritev brings over 45 years of claims and data experience and builds on world-class technology and artificial intelligence ("AI") solutions, to deliver its portfolio of product and service offerings. We exist to address the growing cost, risk and complexity of healthcare in the United States.

Financial trend for Claritev Corp from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $1.08 billion (2022-12-31) to $965.41 million (2025-12-31), a change of -10.6%; net income (loss) went from -$572.91 million (2022-12-31) to -$284.28 million (2025-12-31), a change of +50.4%; total assets went from $7.37 billion (2022-12-31) to $4.89 billion (2025-12-31), a change of -33.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1793229, tags Assets, NetIncomeLoss, RevenueFromContractWithCustomerExcludingAssessedTax; 4 periods shown, dashes mark figures Claritev Corp did not tag for that period.

For the latest news, the fastest official source is the filing feed: Claritev Corp (CIK 1793229) filed 95 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-15, and its overall latest filing is a 4 dated 2026-10-19. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 95 8-K or 6-K reports in Claritev Corp’s recent EDGAR index, the 4 listed here run from 2026-07-06 to 2026-10-15, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1793229 is on the EDGAR company page; the latest 10-K there is dated 2026-02-26 and the oldest filing in the recent index dates from 2019-12-23. Insider trades for Claritev Corp appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Companhia de saneamento de minas gerais bullish and bearish analyst opinions

What this search refers to. Companhia de Saneamento de Minas Gerais (Copasa) is the water and sanitation utility of the Brazilian state of Minas Gerais, listed on B3; its filings are with Brazil’s CVM rather than the SEC. Official source: www.gov.br.

No SEC filer could be matched to “Companhia de saneamento de minas gerais bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Companhia de saneamento de minas gerais” appears in 3442+ EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “companhia” (search terms considered: companhia, saneamento, minas, gerais).

A broader EDGAR full-text search for the shorter phrase “Companhia de saneamento” finds 10000+ filing documents; among the top 100, the filers mentioning it most are COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP (SBS) (CIK 0001170858) (97); Advisors' Inner Circle Fund III (CIK 0001593547) (2); BANK OF NEW YORK / ADR DIVISION (CIK 0001201935) (2). Those are documents that name the term, not proof that any of these filers is the business in the search.

In the 100 most relevant full-text hits returned for “Companhia de saneamento de minas gerais”, filings range from 2006-04-28 to 2026-10-23. The filers whose documents mention it most often are Advisors' Inner Circle Fund III (CIK 0001593547) (24 hits); Global X Funds (CIK 0001432353) (21 hits); JNL SERIES TRUST (CIK 0000933691) (8 hits); BLACKROCK LATIN AMERICA FUND, INC. (CIK 0000877151) (8 hits). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 29 entities whose registered name contains the word “companhia”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “companhia” 29, “saneamento” 4, “minas” 9, “gerais” 4. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “companhia” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Concrete pumping holdings bbcp news october 2026

This section ties “Concrete pumping holdings bbcp news october 2026” to Concrete Pumping Holdings, Inc. (ticker BBCP), SEC Central Index Key 1703956, an EDGAR registrant classified as “Construction - Special Trade Contractors” and organised in DE, formerly known as Industrea Acquisition Corp. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-09-03, and this view starts from filings dated on or before 2026-06-11. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-01-13 by Concrete Pumping Holdings, Inc. (CIK 1703956) (passage 2, continuing from the earlier excerpt) — source document:

Since then, the Company has expanded across the U.S. and U.K. through more than 70 strategic acquisitions. Eco-Pan was founded in 1999 and was acquired by CPH in 2014. Concrete pumping is a highly specialized method of concrete placement that requires skilled operators to position a truck-mounted, fully-articulating boom for precise delivery of ready-mix concrete from mixer trucks to placing crews on a construction job site. In addition, given the rising awareness of environmental factors, proper concrete washout handling is an important area of focus for our Company. We believe that our large fleet of specialized pumping equipment, washout pans and trucks, and highly-trained operators enable us to be the trusted provider of concrete placement and concrete waste management solutions to our customers.

Financial trend for Concrete Pumping Holdings, Inc. from quarterly and annual reports (three-month periods), periods 2026-01-31 to 2026-07-31: revenue went from $90.56 million (2026-01-31) to $116.77 million (2026-07-31), a change of +28.9%; net income (loss) went from -$2.44 million (2026-01-31) to $4.93 million (2026-07-31), a change of +301.9%; total assets went from $883.73 million (2026-01-31) to $908.26 million (2026-07-31), a change of +2.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1703956, tags Assets, NetIncomeLoss, Revenues; 3 periods shown, dashes mark figures Concrete Pumping Holdings, Inc. did not tag for that period.

Current reports. Of the 78 8-K or 6-K reports in Concrete Pumping Holdings, Inc.’s recent EDGAR index, the 4 listed here run from 2025-06-05 to 2026-03-10, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1703956 is on the EDGAR company page; the latest 10-K there is dated 2026-01-13 and the oldest filing in the recent index dates from 2017-05-03. One example from this record is the 144 filed 2026-07-10 (document). Insider trades for Concrete Pumping Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Dream-rsi evolving worlds recursive self-improvement

What this search refers to. “Dream-rsi evolving worlds recursive self-improvement” is an AI-research phrase (RSI usually stands for recursive self-improvement), so it points to a paper, project or model rather than a securities issuer; research of that kind is published on arXiv or in a project repository. Official source: arxiv.org.

No SEC filer could be matched to “Dream-rsi evolving worlds recursive self-improvement” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Dream-rsi evolving worlds recursive self-improvement”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “dream-rsi” (search terms considered: dream-rsi, evolving, worlds, recursive, self-improvement).

Even the shorter phrase “Dream-rsi evolving worlds” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (dream-rsi, evolving, worlds, recursive, self-improvement) point to a business outside the SEC system or one known by another legal name.

EDGAR’s company index has 0 entities whose registered name contains the word “dream-rsi”, so the business is most likely not registered with the SEC under that name.

Word by word, the number of EDGAR registrant names containing each term of this search is: “dream-rsi” 0, “evolving” 4, “worlds” 25, “recursive” 15, “self-improvement” 0. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “evolving”: ALPHA EVOLVING MANAGER FUND LTD (CIK 1175788), EVOLVING GOLD CORP (CIK 1303202), EVOLVING PROCESS LLC (CIK 1602635); containing “worlds”: ACTUAL WORLDS, INC. (CIK 1520593), ALIGN ENTERPRISE II WORLDS FOLLOW-ON II, LP (CIK 2031879), COMPANION WORLDS INC (CIK 1304903); containing “recursive”: AN-1023 FUND I, A SERIES OF RECURSIVE VENTURES, LP (CIK 2095836), DE FUND I, A SERIES OF RECURSIVE VENTURES, LP (CIK 1826449), PL-0807 FUND I, A SERIES OF RECURSIVE VENTURES, LP (CIK 2039199). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: if “dream-rsi” is a brand or product, the listed parent may file under a different name, so search the parent’s legal name in EDGAR company search. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Gores holdings x, inc. units bullish and bearish analyst opinions

This section ties “Gores holdings x, inc. units bullish and bearish analyst opinions” to Gores Holdings X, Inc. (ticker none listed), SEC Central Index Key 1897941, an EDGAR registrant classified as “Blank Checks” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-08-14. Nothing here is a recommendation to trade the security.

Analyst ratings, price targets and “bullish” or “bearish” calls on Gores Holdings X, Inc. (CIK 1897941) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Gores Holdings X, Inc. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 1 such filings (S-1) appear in its recent index, the newest dated 2021-12-20.

What kind of filer this is matters for “Gores holdings x, inc. units bullish and bearish analyst opinions”: Gores Holdings X, Inc.’s EDGAR record from 2021-12-20 to 2026-08-14 consists only of RW filings; S-1 filings; SCHEDULE 13G/A filings; Schedule 13G ownership reports, filed when it held more than 5% of another company’s shares. It has no 10-K, 10-Q or 20-F, so the SEC holds no audited financial statements or annual business description for it.

Other filings. Across its 7 recent EDGAR filings, Gores Holdings X, Inc. most often filed SCHEDULE 13G/A (3), SCHEDULE 13G (2), RW (1), S-1 (1). A selection from 2025-05-08 to 2026-08-14:

The full record for CIK 1897941 is on the EDGAR company page and the oldest filing in the recent index dates from 2021-12-20. Insider trades for Gores Holdings X, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Units of a blank-check company combine one share of Class A common stock with a fraction of a warrant and trade under their own ticker until they separate. Analyst opinion on units is rare; their price mainly tracks the trust value per share plus the market’s view of the eventual merger target.

Gsr v acquisition corp. analyst opinions and stock outlook

This section ties “Gsr v acquisition corp. analyst opinions and stock outlook” to GSR V Acquisition Corp. (ticker GSRV, GSRVR, GSRVU), SEC Central Index Key 2111762, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G dated 2026-10-07, and this view starts from filings dated on or before 2026-05-21. Nothing here is a recommendation to trade the security.

Financial trend for GSR V Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2026-03-31 to 2026-06-30: net income (loss) went from -$56,685 (2026-03-31) to $786,553 (2026-06-30), a change of +1487.6%; total assets went from $75,916 (2026-03-31) to $232.80 million (2026-06-30), a change of +306560.4%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2111762, tags Assets, NetIncomeLoss; 2 periods shown, dashes mark figures GSR V Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on GSR V Acquisition Corp. (CIK 2111762) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for GSR V Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-05-14.

Other filings. Across its 29 recent EDGAR filings, GSR V Acquisition Corp. most often filed SCHEDULE 13G (7), 3 (5), 8-K (3), 10-Q (2). A selection from 2026-05-20 to 2026-08-13:

The full record for CIK 2111762 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-03-30. One example from this record is the SCHEDULE 13G filed 2026-08-14 (document). Insider trades for GSR V Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Hemab therapeutics holdings, inc. common stock bullish and bearish analyst opinions

Analyst ratings, price targets and “bullish” or “bearish” calls on Hemab Therapeutics Holdings, Inc. (CIK 2114044) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-11. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Other filings. Across its 50 recent EDGAR filings, Hemab Therapeutics Holdings, Inc. most often filed 3 (12), 4 (10), SCHEDULE 13G (8), 8-K (5). A selection from 2026-05-01 to 2026-05-04:

The full record for CIK 2114044 is on the EDGAR company page and the oldest filing in the recent index dates from 2026-02-27. One example from this record is the 10-Q filed 2026-05-21 (document). Insider trades for Hemab Therapeutics Holdings, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Jerash holdings (us), inc. bullish and bearish analyst opinions

This section ties “Jerash holdings (us), inc. bullish and bearish analyst opinions” to Jerash Holdings (US), Inc. (ticker JRSH), SEC Central Index Key 1696558, an EDGAR registrant classified as “Apparel & Other Finishd Prods of Fabrics & Similar Matl” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-09-11. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-06-18 by Jerash Holdings (US), Inc. (CIK 1696558) — source document:

Jerash Holdings (US), Inc. (“Jerash Holdings”), through its wholly owned operating subsidiaries (together, the “Group,” “we,” “us,” or “our”), is principally engaged in the manufacturing and exporting of customized, ready-made sportswear and outerwear from knitted fabric produced in its facilities in the Hashemite Kingdom of Jordan (“Jordan”). Our website address is http://www.jerashholdings.com. Information available on our website is not a part of, and is not incorporated into, this Annual Report on Form 10-K. We are a manufacturer for several well-known brands and retailers, such as VF Corporation (which owns brands such as The North Face, Timberland, and Vans), New Balance, G-III (which owns DKNY and licenses brands such as Calvin Klein, Tommy Hilfiger, and Nautica), Hugo Boss, American Eagle, and Acushnet (which owns brands such as Footjoy and Titleist).

Financial trend for Jerash Holdings (US), Inc. from annual reports, periods 2023-03-31 to 2026-03-31: revenue went from $138.06 million (2023-03-31) to $166.26 million (2026-03-31), a change of +20.4%; net income (loss) went from $2.42 million (2023-03-31) to $3.54 million (2026-03-31), a change of +46.2%; total assets went from $83.72 million (2023-03-31) to $89.85 million (2026-03-31), a change of +7.3%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1696558, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Jerash Holdings (US), Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Jerash Holdings (US), Inc. (CIK 1696558) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-10, and the most recent 10-K annual report was filed 2026-06-18. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 118 8-K or 6-K reports in Jerash Holdings (US), Inc.’s recent EDGAR index, the 4 listed here run from 2026-07-21 to 2026-09-11, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1696558 is on the EDGAR company page; the latest 10-K there is dated 2026-06-18 and the oldest filing in the recent index dates from 2017-01-31. Insider trades for Jerash Holdings (US), Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Lightwave acquisition corp. bullish and bearish analyst opinions

This section ties “Lightwave acquisition corp. bullish and bearish analyst opinions” to LightWave Acquisition Corp. (ticker LWAC, LWACU, LWACW), SEC Central Index Key 2061379, an EDGAR registrant classified as “Blank Checks” and organised in an unstated jurisdiction. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 10-Q dated 2026-08-14, and this view starts from filings dated on or before 2025-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-31 by LightWave Acquisition Corp. (CIK 2061379) (passage 2, continuing from the earlier excerpt) — source document:

The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $215,625,000. Simultaneously with the closing of the IPO, the Company completed the private placement of an aggregate of 606,250 units (the “Private Placement Units”) to the Sponsor and BTIG, LLC, the representative of the underwriters, at $10.00 per Private Placement Unit, each Private Placement Unit consisting of one Class A ordinary share and one-half of one redeemable Warrant, each whole Warrant exercisable to purchase one Class A ordinary share. Of those 606,250 Private Placement Units, the Sponsor purchased 390,625 Private Placement Units and BTIG, LLC purchased 215,625 Private Placement Units. The Warrants contained in the Private Placement Units are identical to the Warrants included in the Units sold in the IPO, except as otherwise disclosed in the registration statement filed with the SEC relating to the IPO. No underwriting discounts or commissions were paid with respect to such sale.

Financial trend for LightWave Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2025-09-30 to 2026-06-30: net income (loss) went from $2.11 million (2025-09-30) to $1.63 million (2026-06-30), a change of -22.7%; total assets went from $219.07 million (2025-09-30) to $224.60 million (2026-06-30), a change of +2.5%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2061379, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures LightWave Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on LightWave Acquisition Corp. (CIK 2061379) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-31. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for LightWave Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 5 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2025-06-26.

Other filings. Across its 38 recent EDGAR filings, LightWave Acquisition Corp. most often filed 10-Q (5), 3 (5), SCHEDULE 13G/A (4), SCHEDULE 13G (4). A selection from 2025-08-14 to 2025-11-14:

The full record for CIK 2061379 is on the EDGAR company page; the latest 10-K there is dated 2026-03-31 and the oldest filing in the recent index dates from 2025-03-21. One example from this record is the SCHEDULE 13G/A filed 2026-02-11 (document). Insider trades for LightWave Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Limoneira co. food products news

This section ties “Limoneira co. food products news” to Limoneira CO (ticker LMNR), SEC Central Index Key 1342423, an EDGAR registrant classified as “Agricultural Production-Crops” and organised in DE. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-22. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2025-12-23 by Limoneira CO (CIK 1342423) — source document:

Limoneira Company, a Delaware corporation, is the successor to several businesses with operations in California since 1893. Our business and operations are described below. For detailed financial information with respect to our business and our operations, see our consolidated financial statements and the related notes to consolidated financial statements, which are included in Item 8 in this Annual Report. In addition, general information concerning our Company can be found on our website at www.limoneira.com. All of our filings with the SEC, including but not limited to, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments thereto, are available free of charge on our website as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. The contents of our website referred to above are not incorporated into this Annual Report.

Financial trend for Limoneira CO from annual reports, periods 2022-10-31 to 2025-10-31: revenue went from $184.60 million (2022-10-31) to $159.72 million (2025-10-31), a change of -13.5%; net income (loss) went from -$236,000 (2022-10-31) to -$15.98 million (2025-10-31), a change of -6671.6%; total assets went from $368.52 million (2022-10-31) to $311.14 million (2025-10-31), a change of -15.6%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1342423, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Limoneira CO did not tag for that period.

For the latest news, the fastest official source is the filing feed: Limoneira CO (CIK 1342423) filed 230 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-22, and its overall latest filing is a 8-K dated 2026-10-22. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 230 8-K or 6-K reports in Limoneira CO’s recent EDGAR index, the 4 listed here run from 2026-06-18 to 2026-10-22, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1342423 is on the EDGAR company page; the latest 10-K there is dated 2025-12-23 and the oldest filing in the recent index dates from 2005-10-27. Insider trades for Limoneira CO appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Martin midstream partners mmlp latest news october 2026

This section ties “Martin midstream partners mmlp latest news october 2026” to MARTIN MIDSTREAM PARTNERS L.P. (ticker MMLP), SEC Central Index Key 1176334, an EDGAR registrant classified as “Wholesale-Petroleum Bulk Stations & Terminals” and organised in DE, formerly known as MARTIN MIDSTREAM PARTNERS LP. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a 8-K dated 2026-10-21. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-02-23 by MARTIN MIDSTREAM PARTNERS L.P. (CIK 1176334) — source document:

References in this Annual Report on Form 10-K for the year ended December 31, 2025 (this "Annual Report") to "we," "ours," "us" or like terms when used in a historical context refer to the assets and operations of Martin Resource Management Corporation's business contributed to us in connection with our initial public offering on November 6, 2002. References in this Annual Report to "Martin Resource Management Corporation" refer to Martin Resource Management Corporation and its subsidiaries, unless the context otherwise requires. References in this Annual Report to the "Partnership" refer to Martin Midstream Partners L.P. and its subsidiaries, unless the content otherwise requires. You should read the following discussion of our financial condition and results of operations in conjunction with the consolidated financial statements and the notes thereto included elsewhere in this Annual Report.

Financial trend for MARTIN MIDSTREAM PARTNERS L.P. from annual reports, periods 2022-12-31 to 2025-12-31: net income (loss) went from -$10.33 million (2022-12-31) to -$14.74 million (2025-12-31), a change of -42.7%; total assets went from $598.85 million (2022-12-31) to $522.42 million (2025-12-31), a change of -12.8%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1176334, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures MARTIN MIDSTREAM PARTNERS L.P. did not tag for that period.

For the latest news, the fastest official source is the filing feed: MARTIN MIDSTREAM PARTNERS L.P. (CIK 1176334) filed 124 current reports (8-K or 6-K) in its recent EDGAR window, the newest on 2026-10-21, and its overall latest filing is a 8-K dated 2026-10-21. Companies must file an 8-K within four business days of most material events.

Current reports. Of the 124 8-K or 6-K reports in MARTIN MIDSTREAM PARTNERS L.P.’s recent EDGAR index, the 4 listed here run from 2026-04-06 to 2026-10-21, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 1176334 is on the EDGAR company page; the latest 10-K there is dated 2026-02-23 and the oldest filing in the recent index dates from 2013-01-04. Insider trades for MARTIN MIDSTREAM PARTNERS L.P. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Mastech digital, inc. bullish and bearish analyst opinions

This section ties “Mastech digital, inc. bullish and bearish analyst opinions” to Mastech Digital, Inc. (ticker MHH), SEC Central Index Key 1437226, an EDGAR registrant classified as “Services-Management Consulting Services” and organised in PA, formerly known as Mastech Holdings, Inc. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G/A dated 2026-10-22. Nothing here is a recommendation to trade the security.

Financial trend for Mastech Digital, Inc. from annual reports, periods 2022-12-31 to 2025-12-31: revenue went from $242.24 million (2022-12-31) to $191.37 million (2025-12-31), a change of -21.0%; net income (loss) went from $8.71 million (2022-12-31) to $609,000 (2025-12-31), a change of -93.0%; total assets went from $108.88 million (2022-12-31) to $111.84 million (2025-12-31), a change of +2.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 1437226, tags Assets, NetIncomeLoss, Revenues; 4 periods shown, dashes mark figures Mastech Digital, Inc. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Mastech Digital, Inc. (CIK 1437226) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on: the latest results release filed under 8-K Item 2.02 is dated 2026-08-06, and the most recent 10-K annual report was filed 2026-03-18. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Current reports. Of the 152 8-K or 6-K reports in Mastech Digital, Inc.’s recent EDGAR index, the 4 listed here run from 2026-05-15 to 2026-08-14, with the item codes the company selected and what each code covers under SEC rules.

Other filings. Across its 588 recent EDGAR filings, Mastech Digital, Inc. most often filed 4 (198), 8-K (152), 10-Q (54), 3 (29). A selection from 2026-08-06 to 2026-10-22:

The full record for CIK 1437226 is on the EDGAR company page; the latest 10-K there is dated 2026-03-18 and the oldest filing in the recent index dates from 2008-06-11. Insider trades for Mastech Digital, Inc. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET

Nath bio-genes (india) limited bullish and bearish analyst opinions

Read from its name, “Nath bio-genes (india) limited” is a India entity — “Private Limited” (Pvt Ltd) is an Indian private company form whose shares cannot be offered to the public. Its accounts and exchange notices are published through the Ministry of Corporate Affairs (MCA) company master data and, for listed firms, BSE/NSE filings (www.mca.gov.in); the SEC only receives filings from such a company if it sells registered securities in the U.S.

No SEC filer could be matched to “Nath bio-genes (india) limited bullish and bearish analyst opinions” with a single, clear Central Index Key: the phrase “Nath bio-genes india limited” appears in 1 EDGAR full-text search results, but those hits do not point to one clearly identifiable issuer with its own CIK. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “nath” (search terms considered: nath, bio-genes, india).

Even the shorter phrase “Nath bio-genes limited” returns no EDGAR full-text hits, so no SEC filing since 2001 mentions it; the terms in this search (nath, bio-genes, india) point to a business outside the SEC system or one known by another legal name.

The wording suggests a business based in India. Companies there file with NSE/BSE and the Securities and Exchange Board of India (SEBI) rather than with the U.S. SEC, unless they also list shares or ADRs in the United States. The primary disclosure route for “nath” is therefore the India regulator or exchange site, where annual reports and stock-exchange announcements are published.

In the 1 most relevant full-text hits returned for “Nath bio-genes india limited”, filings range from 2025-04-18 to 2025-04-18. The filers whose documents mention it most often are Moolec Science SA (MLEC, MLECW) (CIK 0001937737) (1 hit). A mention in another company’s filing — as a customer, supplier, lender, fund holding or deal counterparty — does not make that filer the company you searched for.

EDGAR’s company index has 13 entities whose registered name contains the word “nath”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “nath” 13, “bio-genes” 0, “india” 472. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

For this particular search: analyst views on “nath” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Omer s.p.a. bullish and bearish analyst opinions

The legal-form ending in “Omer s.p.a.” is the clue: “S.p.A.” is the Italian joint-stock company form (società per azioni). A company of that kind reports in Italy, so the place to read its annual report and announcements is Borsa Italiana and CONSOB’s issuer disclosures — www.consob.it.

No SEC filer could be matched to “Omer s.p.a. bullish and bearish analyst opinions” with a single, clear Central Index Key: neither EDGAR’s company index nor its full-text search (phrase “Omer s.p.a.”) returns a registrant with this name. Rather than show another company’s numbers, this section explains what the official record does and does not contain for the term “omer” (search terms considered: omer).

EDGAR’s company index has 23 entities whose registered name contains the word “omer”; the first few are shown below so you can see whether any is the business you mean. None of them matches the full search wording closely enough to be treated as the same company.

Word by word, the number of EDGAR registrant names containing each term of this search is: “omer” 23. A term that appears in many unrelated names is a weak identifier on its own, which is why this page does not attach any one filer’s financial data to the query.

Sample EDGAR registrant names, term by term — containing “omer”: AL-ZAWAWI WALEED OMER ABDUL-MONEM (CIK 1630512), BROWN OMER STEPHEN (CIK 1341598), COHEN OMER (CIK 1751041). These are listed only to show how the individual words map onto unrelated filers; none should be read as the subject of the search.

For this particular search: analyst views on “omer” are third-party opinions; the SEC neither issues nor reviews ratings, so check any rating against the company’s own annual report. If the business says it is registered but does not appear in EDGAR or on FINRA BrokerCheck, treat that as a red flag. This page offers no buy or sell recommendation.

Updated Oct 25, 2026 ET

Praetorian acquisition corp. bullish and bearish analyst opinions

This section ties “Praetorian acquisition corp. bullish and bearish analyst opinions” to Praetorian Acquisition Corp. (ticker PTOR, PTORU, PTORW), SEC Central Index Key 2093912, an EDGAR registrant classified as “Blank Checks” and organised in Cayman Islands. The figures and filings below were read from EDGAR on Oct 25, 2026; the most recent filing on record is a SCHEDULE 13G dated 2026-08-14. Nothing here is a recommendation to trade the security.

Business description, quoted from the 10-K filed 2026-03-27 by Praetorian Acquisition Corp. (CIK 2093912) — source document:

We are a blank check company incorporated on September 29, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. To date, we have not selected any business combination target and our efforts have been limited to (i) organizational activities, (ii) activities related to our Initial Public Offering, and (iii) searching for a business combination target. We have also generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.

Financial trend for Praetorian Acquisition Corp. from quarterly and annual reports (three-month periods), periods 2025-12-31 to 2026-06-30: net income (loss) went from -$49,204 (2025-12-31) to $1.01 million (2026-06-30), a change of +2149.4%; total assets went from $264,716 (2025-12-31) to $258.76 million (2026-06-30), a change of +97651.7%. Values are as filed and not adjusted for restatements, splits or currency.

Data: SEC XBRL company facts for CIK 2093912, tags Assets, NetIncomeLoss; 3 periods shown, dashes mark figures Praetorian Acquisition Corp. did not tag for that period.

Analyst ratings, price targets and “bullish” or “bearish” calls on Praetorian Acquisition Corp. (CIK 2093912) are third-party opinions that the SEC does not publish or check. What the regulator does hold are the facts those views are built on, and the most recent 10-K annual report was filed 2026-03-27. Comparing any rating with those primary documents shows whether the thesis matches what the company itself reported.

Deal and listing documents for Praetorian Acquisition Corp. — registration statements, prospectuses and merger proxies — are filed on EDGAR; 3 such filings (424B4, S-1, S-1/A) appear in its recent index, the newest dated 2026-01-26.

Current reports. Of the 4 8-K or 6-K reports in Praetorian Acquisition Corp.’s recent EDGAR index, the 4 listed here run from 2026-01-27 to 2026-03-19, with the item codes the company selected and what each code covers under SEC rules.

The full record for CIK 2093912 is on the EDGAR company page; the latest 10-K there is dated 2026-03-27 and the oldest filing in the recent index dates from 2025-11-17. Insider trades for Praetorian Acquisition Corp. appear as Forms 3, 4 and 5, and holders above 5% file Schedules 13D or 13G.

Updated Oct 25, 2026 ET